Cargando…

Detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score

BACKGROUND: Recommendations for screening patients with lower-extremity arterial disease (LEAD) to detect asymptomatic carotid stenosis (ACS) are conflicting. Prediction models might identify patients at high risk of ACS, possibly allowing targeted screening to improve preventive therapy and complia...

Descripción completa

Detalles Bibliográficos
Autores principales: Poorthuis, M H F, Morris, D R, de Borst, G J, Bots, M L, Greving, J P, Visseren, F L J, Sherliker, P, Clack, R, Clarke, R, Lewington, S, Bulbulia, R, Halliday, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364916/
https://www.ncbi.nlm.nih.gov/pubmed/33876207
http://dx.doi.org/10.1093/bjs/znab040
_version_ 1785076942890860544
author Poorthuis, M H F
Morris, D R
de Borst, G J
Bots, M L
Greving, J P
Visseren, F L J
Sherliker, P
Clack, R
Clarke, R
Lewington, S
Bulbulia, R
Halliday, A
author_facet Poorthuis, M H F
Morris, D R
de Borst, G J
Bots, M L
Greving, J P
Visseren, F L J
Sherliker, P
Clack, R
Clarke, R
Lewington, S
Bulbulia, R
Halliday, A
author_sort Poorthuis, M H F
collection PubMed
description BACKGROUND: Recommendations for screening patients with lower-extremity arterial disease (LEAD) to detect asymptomatic carotid stenosis (ACS) are conflicting. Prediction models might identify patients at high risk of ACS, possibly allowing targeted screening to improve preventive therapy and compliance. METHODS: A systematic search for prediction models for at least 50 per cent ACS in patients with LEAD was conducted. A prediction model in screened patients from the USA with an ankle : brachial pressure index of 0.9 or less was subsequently developed, and assessed for discrimination and calibration. External validation was performed in two independent cohorts, from the UK and the Netherlands. RESULTS: After screening 4907 studies, no previously published prediction models were found. For development of a new model, data for 112 117 patients were used, of whom 6354 (5.7 per cent) had at least 50 per cent ACS and 2801 (2.5 per cent) had at least 70 per cent ACS. Age, sex, smoking status, history of hypercholesterolaemia, stroke/transient ischaemic attack, coronary heart disease and measured systolic BP were predictors of ACS. The model discrimination had an area under the receiver operating characteristic (AUROC) curve of 0.71 (95 per cent c.i. 0.71 to 0.72) for at least 50 per cent ACS and 0.73 (0.72 to 0.73) for at least 70 per cent ACS. Screening the 20 per cent of patients at greatest risk detected 12.4 per cent with at least 50 per cent ACS (number needed to screen (NNS) 8] and 5.8 per cent with at least 70 per cent ACS (NNS 17). This yielded 44.2 and 46.9 per cent of patients with at least 50 and 70 per cent ACS respectively. External validation showed reliable discrimination and adequate calibration. CONCLUSION: The present risk score can predict significant ACS in patients with LEAD. This approach may inform targeted screening of high-risk individuals to enhance the detection of ACS.
format Online
Article
Text
id pubmed-10364916
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103649162023-07-31 Detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score Poorthuis, M H F Morris, D R de Borst, G J Bots, M L Greving, J P Visseren, F L J Sherliker, P Clack, R Clarke, R Lewington, S Bulbulia, R Halliday, A Br J Surg Original Articles BACKGROUND: Recommendations for screening patients with lower-extremity arterial disease (LEAD) to detect asymptomatic carotid stenosis (ACS) are conflicting. Prediction models might identify patients at high risk of ACS, possibly allowing targeted screening to improve preventive therapy and compliance. METHODS: A systematic search for prediction models for at least 50 per cent ACS in patients with LEAD was conducted. A prediction model in screened patients from the USA with an ankle : brachial pressure index of 0.9 or less was subsequently developed, and assessed for discrimination and calibration. External validation was performed in two independent cohorts, from the UK and the Netherlands. RESULTS: After screening 4907 studies, no previously published prediction models were found. For development of a new model, data for 112 117 patients were used, of whom 6354 (5.7 per cent) had at least 50 per cent ACS and 2801 (2.5 per cent) had at least 70 per cent ACS. Age, sex, smoking status, history of hypercholesterolaemia, stroke/transient ischaemic attack, coronary heart disease and measured systolic BP were predictors of ACS. The model discrimination had an area under the receiver operating characteristic (AUROC) curve of 0.71 (95 per cent c.i. 0.71 to 0.72) for at least 50 per cent ACS and 0.73 (0.72 to 0.73) for at least 70 per cent ACS. Screening the 20 per cent of patients at greatest risk detected 12.4 per cent with at least 50 per cent ACS (number needed to screen (NNS) 8] and 5.8 per cent with at least 70 per cent ACS (NNS 17). This yielded 44.2 and 46.9 per cent of patients with at least 50 and 70 per cent ACS respectively. External validation showed reliable discrimination and adequate calibration. CONCLUSION: The present risk score can predict significant ACS in patients with LEAD. This approach may inform targeted screening of high-risk individuals to enhance the detection of ACS. Oxford University Press 2021-04-19 /pmc/articles/PMC10364916/ /pubmed/33876207 http://dx.doi.org/10.1093/bjs/znab040 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Poorthuis, M H F
Morris, D R
de Borst, G J
Bots, M L
Greving, J P
Visseren, F L J
Sherliker, P
Clack, R
Clarke, R
Lewington, S
Bulbulia, R
Halliday, A
Detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score
title Detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score
title_full Detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score
title_fullStr Detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score
title_full_unstemmed Detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score
title_short Detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score
title_sort detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364916/
https://www.ncbi.nlm.nih.gov/pubmed/33876207
http://dx.doi.org/10.1093/bjs/znab040
work_keys_str_mv AT poorthuismhf detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT morrisdr detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT deborstgj detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT botsml detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT grevingjp detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT visserenflj detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT sherlikerp detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT clackr detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT clarker detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT lewingtons detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT bulbuliar detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore
AT hallidaya detectionofasymptomaticcarotidstenosisinpatientswithlowerextremityarterialdiseasedevelopmentandexternalvalidationsofariskscore